Harvard Heart Letter

New drug offers warfarin alternative for atrial fibrillation

People who take the blood thinner warfarin have a new option, Pradaxa, which is not affected by diet and does not require its dosage to be fine-tuned.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In